Menu

The Retinoid Strength Ladder: Chemistry That Holds, Evidence That Does Not

The retinoid strength ladder is ordered by conversion steps, but the trial evidence for the over-the-counter rungs is thinner than the ordering suggests.

By Iris Vance · September 1, 2026 · 11 min read

Iris Vance writes as a researcher, not a dermatologist or licensed esthetician. Nothing here diagnoses or treats. How we work.

Macro close-up of skin showing pores and surface texture against a dark background.

The Retinoid Strength Ladder: Chemistry That Holds, Evidence That Does Not

The retinoid strength ladder is real as chemistry: every form except retinoic acid has to be converted inside the skin, and each conversion step is a place where less of it arrives. What the ladder does not tell you is how far apart the rungs actually are, or whether the lower ones do anything measurable at all.

Those are two different questions, and the published answers to them are not equally strong. The ordering is well described. The clinical evidence for the rungs sold over the counter is thin enough that a systematic review of it reached an unusually blunt conclusion.

The ladder as chemistry

Only one form is active on arrival. Everything else is a precursor, and a systematic review of over-the-counter vitamin A products in the Journal of Clinical and Aesthetic Dermatology puts the requirement plainly: They require conversion to active retinoic acid in the body to demonstrate activity.

That gives the ordering its logic. The further down the ladder a molecule sits, the more conversion it needs, and conversion is not free. The review makes the point at the bottom rung specifically, noting that retinyl palmitate is the most commonly used retinol in cosmetic skincare products but is theoretically the least effective because it requires conversion to active retinoic acid by a two-step oxidative process, which is limited in the skin.

Two words in that sentence are doing a lot of work. Theoretically, because the ordering is inferred from the chemistry rather than measured between products. And limited in the skin, which is the part the marketing leaves out: the conversion is not assumed to run to completion.

What the over-the-counter rungs actually have behind them

This is where the ladder stops being a story about potency and starts being a story about evidence.

The same review searched the clinical trial literature for retinol and its relatives and reports what it found: Nine randomized, double-blind, vehicle-controlled clinical trials were found. Nine is not many for an ingredient this widely sold.

The results split badly. Four of these trials reported no statistically significant differences between the retinol-containing treatment and vehicle, meaning the product performed the same as the cream base it was mixed into. Of the rest, The remaining five trials provide weak evidence for retinol potentially having a mild ameliorating effect on fine facial skin wrinkle lines only.

Then the review turns on those five as well: The remaining five trials have major methodological flaws affecting design and analysis, which calls into question any positive results obtained.

Its overall position is stated without hedging: Until at least one high-quality clinical trial of retinol-containing products in the treatment of (photo-)aged skin is published, there is very little, if any, trustworthy evidence available to support the use of over-the-counter cosmetic retinol-containing products.

Two limits on how far that should be taken. It is one review, of one endpoint, in one population: cosmetic retinol for photoaged skin. It is not a statement about retinoids in acne, where the prescription forms are first-line, which retinol versus retinoid covers with its own sources. And a review finding the evidence weak is different from evidence of no effect. The honest summary is that the case for cosmetic retinol rests on trials that this review considers unable to carry it.

Where retinaldehyde sits, stated carefully

Retinaldehyde is the rung usually marketed as the strongest thing available without a prescription, on the logic that it is one conversion step from retinoic acid instead of two. The chemistry behind that claim is the same chemistry described above, and it is reasonable on its face.

What I can report about the evidence is bounded rather than sweeping. The review searched the literature using the terms “retinoid,” “tretinoin,” “retinol,” “retinal,” “retinaldehyde,” and “skin.” Its nine included trials were retinol-containing. So the review does not settle where retinaldehyde lands, and neither does this page. What it does establish is that the multiplier claims attached to retinaldehyde in product copy are not coming from this body of evidence.

The rung with a documented time course

One rung has trial evidence with a timeline attached, and it is worth knowing what that timeline looks like, because it reframes what a disappointing eight weeks means.

The review states that Aside from the obvious difference in retinol strengths, trial evidence suggests that topical tretinoin treatment improves the clinical appearance of (photo-)aged skin only after three to six months of treatment, and notes that many trials show most of the clinically noticeable improvement arriving after six months.

That number is the useful one to carry around. It is also the reason short cosmetic trials are worth reading suspiciously: an eight-week study reporting a clear effect is claiming something faster than the prescription-strength molecule managed in the trial literature. Reading clinical claims covers the rest of what to check in a study a product cites, starting with what its control group was given. How long skincare takes to work sets out the same expectation problem across other categories.

The rungs, graded

Grades follow how we rate skincare evidence and describe the published literature, not any product.

Retinyl palmitate. Limited. The bottom rung, two conversion steps away, described in the review as theoretically the least effective and hampered by conversion that is limited in the skin.

Retinol. Limited. The most-sold form, and the one the systematic review examined directly: nine trials, four null against vehicle, five with major methodological flaws.

Retinaldehyde. Limited. One step from retinoic acid, which is a chemistry argument rather than a trial result. Not settled by the review above.

Adapalene. Strong, in acne. A prescription-class retinoid sold over the counter in the United States with its concentration on the label. DermNet ranks it for tolerability: Adapalene is the least irritating topical retinoid, and tretinoin the most.

Tretinoin. Strong, and prescription only. The active form, no conversion required, with the three-to-six-month time course above and the highest irritation of the class.

The pattern is worth naming: the rungs with the strongest evidence are the ones regulated as drugs, and the ones sold as cosmetics are where the evidence thins out. That is not a coincidence of chemistry. Drugs have to prove things.

So how do you climb it

Sequencing is where this page ends and clinical judgment begins, so these are notes on tolerance rather than on treatment.

Start below where you think you should. Retinoid dermatitis is the expected cost of starting too high too fast, and it is avoidable by frequency rather than by strength.

Move by frequency first, not by rung. StatPearls describes the standard approach for topical retinoids: as tolerance improves, the frequency of application can be increased gradually over a few weeks until daily use is achieved. Daily use of a lower rung comes before any move to a higher one.

Give each rung months, not weeks. The tretinoin timeline above is the fairest yardstick available, and nothing below it acts faster than the thing above it.

Anything involving a prescription is a conversation with a clinician, including whether to have one at all, and including whether hair removal is safe on treated skin, which can you wax while using retinol shows is answered on one rung's label and on no other. What is useful to bring to that conversation is what you have already tolerated and for how long, which is exactly what climbing by frequency produces.

The ladder, side by side

Rung Conversion steps to retinoic acid Regulated as Evidence state
Retinyl palmitate Two Cosmetic Limited; called theoretically least effective
Retinol One, after ester hydrolysis Cosmetic Limited; nine trials, four null, five flawed
Retinaldehyde One Cosmetic Limited; not resolved by the review here
Adapalene None OTC drug in the US Strong in acne; least irritating of the class
Tretinoin None Prescription Strong; improvement documented at three to six months

FAQ

Is retinaldehyde stronger than retinol? The chemistry argument is that it sits one conversion step from retinoic acid rather than two, which is a reasonable basis for expecting more activity. The systematic review discussed here included retinal and retinaldehyde in its search terms, and the nine trials it analyzed were retinol-containing, so it does not establish the size of that difference.

Does retinyl palmitate work? It is described in the review as theoretically the least effective of the cosmetic forms, because it needs a two-step oxidative conversion that is limited in the skin. It is also the most commonly used, which is a fact about formulating cost rather than about efficacy.

How long does retinol take to work? The comparison worth using is the prescription form: trial evidence puts noticeable improvement in photoaged skin at three to six months of tretinoin, with much of it after six. Nothing sold as a cosmetic should be expected to beat that.

Is retinol as good as tretinoin? Not on the evidence as it stands. Tretinoin has trial evidence with a documented time course; the systematic review of over-the-counter retinol found nine trials, four showing no difference from vehicle and five with major methodological flaws.

What is the strongest retinoid you can buy without a prescription? In the United States, adapalene, which is a prescription-class retinoid sold over the counter with its strength printed on the Drug Facts panel. Retinol versus retinoid covers why that regulatory detail matters more than any percentage on a cosmetic label.


The ladder is a useful mental model as long as it is used for what it is: an ordering by conversion steps, not a scale with known distances between the rungs. The distances are where the marketing lives, and the trial literature underneath the cosmetic rungs is thinner than almost any product page implies.

Sources